JPS6127389B2 - - Google Patents
Info
- Publication number
- JPS6127389B2 JPS6127389B2 JP59087963A JP8796384A JPS6127389B2 JP S6127389 B2 JPS6127389 B2 JP S6127389B2 JP 59087963 A JP59087963 A JP 59087963A JP 8796384 A JP8796384 A JP 8796384A JP S6127389 B2 JPS6127389 B2 JP S6127389B2
- Authority
- JP
- Japan
- Prior art keywords
- oxide
- nicotinate
- formula
- alkyl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19833315877 DE3315877A1 (de) | 1983-05-02 | 1983-05-02 | N-oxide von pyridyl-carbonsaeureestern, ein verfahren zu ihrer herstellung und pharmazeutische mittel, die diese verbindungen enthalten |
| DE3315877.0 | 1983-05-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59206357A JPS59206357A (ja) | 1984-11-22 |
| JPS6127389B2 true JPS6127389B2 (enExample) | 1986-06-25 |
Family
ID=6197884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59087963A Granted JPS59206357A (ja) | 1983-05-02 | 1984-05-02 | ピリジルカルボン酸エステルのｎ−酸化物 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4758581A (enExample) |
| JP (1) | JPS59206357A (enExample) |
| KR (1) | KR860001907B1 (enExample) |
| AU (1) | AU564780B2 (enExample) |
| BE (1) | BE899558A (enExample) |
| CA (1) | CA1247092A (enExample) |
| CH (1) | CH660005A5 (enExample) |
| CS (1) | CS241082B2 (enExample) |
| DE (1) | DE3315877A1 (enExample) |
| DK (1) | DK159105C (enExample) |
| ES (1) | ES532079A0 (enExample) |
| FI (1) | FI80444C (enExample) |
| FR (1) | FR2545486B1 (enExample) |
| GB (1) | GB2139621B (enExample) |
| GR (1) | GR79862B (enExample) |
| HU (1) | HU191681B (enExample) |
| IE (1) | IE57393B1 (enExample) |
| IL (1) | IL71734A (enExample) |
| IT (1) | IT1206144B (enExample) |
| LU (1) | LU85344A1 (enExample) |
| NL (1) | NL8401357A (enExample) |
| SE (1) | SE454986B (enExample) |
| YU (1) | YU45900B (enExample) |
| ZA (1) | ZA843278B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6080428A (en) | 1993-09-20 | 2000-06-27 | Bova; David J. | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
| US6746691B2 (en) | 1993-09-20 | 2004-06-08 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
| US6818229B1 (en) | 1993-09-20 | 2004-11-16 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia |
| US6129930A (en) | 1993-09-20 | 2000-10-10 | Bova; David J. | Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night |
| US6676967B1 (en) | 1993-09-20 | 2004-01-13 | Kos Pharmaceuticals, Inc. | Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1256M (fr) * | 1961-06-26 | 1962-04-16 | M I P Soc Amilloise De Prod Ch | Médicament hypocholésterolémiant a base de n-oxyde de l'acide nicotinique. |
| GB1213162A (en) * | 1966-11-16 | 1970-11-18 | Astra Ab | Serum lipid lowering pyridine derivatives and their preparation |
| AT291853B (de) * | 1967-03-22 | 1971-08-10 | Buero Patent Ag | Automatische, gleislose Förderanlage |
| US4321268A (en) * | 1979-02-08 | 1982-03-23 | Merz & Co. | Certain substituted phenyl esters of nicotinic acid, compositions and methods of using same |
| DE3009099A1 (de) * | 1980-03-10 | 1981-09-17 | Merz + Co GmbH & Co, 6000 Frankfurt | Neue phenylester der nikotinsaeure und verfahren zu ihrer herstellung |
| GB2193359B (en) * | 1986-07-31 | 1990-07-11 | Multitone Electronics Plc | Area communications systems |
| US4797656A (en) * | 1987-01-28 | 1989-01-10 | Keppler Charles N | Appliance paging system |
| US5012749A (en) * | 1988-12-27 | 1991-05-07 | The Allen Group Inc. | Radio controlled material handling apparatus |
| US4962377A (en) * | 1989-02-09 | 1990-10-09 | Motorola, Inc. | Paging by text matching |
-
1983
- 1983-05-02 DE DE19833315877 patent/DE3315877A1/de active Granted
-
1984
- 1984-04-26 SE SE8402297A patent/SE454986B/sv not_active IP Right Cessation
- 1984-04-26 YU YU74384A patent/YU45900B/sh unknown
- 1984-04-26 CH CH2092/84A patent/CH660005A5/de not_active IP Right Cessation
- 1984-04-27 NL NL8401357A patent/NL8401357A/nl not_active Application Discontinuation
- 1984-04-28 HU HU841684A patent/HU191681B/hu not_active IP Right Cessation
- 1984-04-30 GR GR74551A patent/GR79862B/el unknown
- 1984-04-30 ES ES532079A patent/ES532079A0/es active Granted
- 1984-04-30 KR KR1019840002323A patent/KR860001907B1/ko not_active Expired
- 1984-05-01 IE IE1074/84A patent/IE57393B1/en not_active IP Right Cessation
- 1984-05-01 GB GB08411081A patent/GB2139621B/en not_active Expired
- 1984-05-01 CA CA000453248A patent/CA1247092A/en not_active Expired
- 1984-05-01 DK DK216484A patent/DK159105C/da not_active IP Right Cessation
- 1984-05-02 IT IT8420763A patent/IT1206144B/it active
- 1984-05-02 AU AU27604/84A patent/AU564780B2/en not_active Ceased
- 1984-05-02 FI FI841736A patent/FI80444C/fi not_active IP Right Cessation
- 1984-05-02 FR FR8406845A patent/FR2545486B1/fr not_active Expired
- 1984-05-02 BE BE0/212858A patent/BE899558A/fr not_active IP Right Cessation
- 1984-05-02 LU LU85344A patent/LU85344A1/fr unknown
- 1984-05-02 IL IL71734A patent/IL71734A/xx unknown
- 1984-05-02 JP JP59087963A patent/JPS59206357A/ja active Granted
- 1984-05-02 ZA ZA843278A patent/ZA843278B/xx unknown
- 1984-05-02 CS CS843252A patent/CS241082B2/cs unknown
-
1987
- 1987-09-29 US US07/102,025 patent/US4758581A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU601657B2 (en) | Quinone derivatives, their production and use | |
| IE60014B1 (en) | Trans-[2-(3-or 4-carboxamido-substituted pyrrol-1 -yl)alkyl]-4-hydroxypyran-2-one inhibitors of cho lesterol synthesis | |
| EP0173172A2 (de) | Neue 3-Pyridylverbindungen und Verfahren zu ihrer Herstellung | |
| USRE32581E (en) | Certain substituted phenyl esters of nicotinic acid, compositions and methods of using same for treatment of hyperlipidemia | |
| JPH0597765A (ja) | ナフトキノン化合物 | |
| EP0325129B1 (de) | Disubstituierte Pyridine | |
| EP0109866B1 (fr) | Nouveaux dérivés de la sulfonylurée, leurs procédés de préparation et les compositions pharmaceutiques les renfermant | |
| JPS6127389B2 (enExample) | ||
| EP0350878B1 (en) | Conjugated gamma-oxybutenolide compounds for treating ulcer | |
| JPH05504961A (ja) | 複素環化合物 | |
| WO1993012089A1 (en) | New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs | |
| US6054591A (en) | Lymph-absorbable aryl substituted imidazole derivatives | |
| US4894391A (en) | Novel prostacyclin derivatives, process for the preparation thereof, and use thereof as medicinal agents | |
| US4278678A (en) | Substituted oxy-cyclohexylacetic acid derivatives | |
| FR2528846A1 (fr) | Nouveau derive de la pyrazolo (1,5-a) pyridine, sa preparation et les compositions pharmaceutiques qui le contiennent | |
| KR100309902B1 (ko) | 디히드로피리딘유도체의신규의약용도 | |
| JP2838282B2 (ja) | 血管攣縮治療剤 | |
| EP0169408A1 (de) | Neue Imidazolylverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| US4103029A (en) | Amino substituted arylthio-alkanoic acids having hypolipidemic activity | |
| JPH07501329A (ja) | 血管拡張活性を有するニトロ化合物 | |
| US4192884A (en) | Substituted 4-(((thienyl)methyl)-amino)benzoic acids and a method for treating hypolipidemia | |
| CA1135689A (en) | Substituted phenol ester containing compounds | |
| US4397852A (en) | [3,6-Pyridazinediylbis(thio)]bis-[2,2-dimethylalkanoic acids] and derivatives as anti-arteriosclerotic agents and method | |
| JPH0733661A (ja) | 脳疾患予防治療剤 | |
| JPS6126790B2 (enExample) |